Polycythemia Vera Treatment Market - Top Companies and Manufacturers

Companies Dominating the Polycythemia Vera Treatment Landscape

Thermo Fisher Scientific Inc.

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

Pfizer Inc.
Galena Biopharma
Bristol-Myers Squibb Company
Novartis AG
Eli Lilly and Company
PharmaEssentia Corporation
Bayer AG
Viatris Inc.
Teva Pharmaceuticals Industries Ltd

Browse Key Market Insights with Data Illustration:

Polycythemia Vera Treatment Market Size, Forecast Report 2037

In the News

PharmaEssentia Corporation, a global biopharmaceutical innovator leveraging deep expertise and proven scientific principles to deliver novel hematology and oncology biologics, has announced reported that the first patients are now receiving treatment from ECLIPSE PV, a phase 3b clinical study evaluating an accelerated dosing regimen for cordeginterferon alfa. -2b-njft uses a prefilled syringe to treat polycythemia vera (PV) in adults.
In November 2021, the US Food and Drug Administration approved Besrem injection for adults with polycythemia vera, a blood disorder that causes overproduction of red blood cells. The extra cells thicken the blood, slowing blood flow and increasing the chance of blood clots.

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of thermosetting plastics is evaluated at USD 4.44 billion.

The polycythemia vera treatment market size was over USD 4.13 billion in 2024 and is poised to exceed USD 13.44 billion by 2037, witnessing over 9.5% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of polycythemia vera and increasing awareness about polycythemia vera treatment will drive the market growth.

North America industry is likely to dominate majority revenue share of 34% by 2037, due to high demand for novel drug delivery system along with development of advanced medication, and increasing investment in R&D activities in the region.

The major players in the market are Pfizer Inc.Galena BiopharmaBristol-Myers Squibb CompanyNovartis AGEli Lilly and CompanyPharmaEssentia CorporationBayer AGViatris Inc.Teva Pharmaceuticals Industries Ltd

Polycythemia Vera Treatment Market - Top Companies and Manufacturers

Companies Dominating the Polycythemia Vera Treatment Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the polycythemia vera treatment market?

What are the factors driving the polycythemia vera treatment landscape?

Which region held the largest polycythemia vera treatment industry share?

Who are the key players in the polycythemia vera treatment sector?